Director of API retires

By Dylan Bushell-Embling
Thursday, 10 July, 2008

A director of Australian Pharmaceutical Industries [ASX: API], Barry Frost, announced his retirement today.

Frost has served on the company's board since 1993, and has been deputy chairman since 2001. His resignation will be effective July 31.

API, which markets and distributes prescription and over-the-counter medications, has announced that it is currently looking for replacement for the position.

Sleep apnoea patients who use CPAP live longer: study

CPAP therapy has been found to significantly reduce the risk of death for people with obstructive...

Does exercise really extend lifespan? It's complicated

Physical activity is seen as a way to extend the human lifespan, but the benefits of physical...

Nature helps to relieve physical pain

Experiencing nature, even in the form of watching nature videos, can alleviate acute physical pain.

Content from other channels on our network

Rising cyber threats to Australia's industrial sector demand urgent action

Cyber attacks on water and electricity operators on the rise: study

Greensteel Australia to build next‍-‍generation steel mill

Omron and Cognizant partner on IT‍–‍OT integration

Encoders in motion control applications: Noise and signal distortion considerations

Reducing upfront carbon in built environment: report

The 3 key risks directors need to manage amid climate reporting uncertainty

Green chemistry turns waste CO2 into amino acids

Circularity needed at scale for Aust building industry

Textile recycler BlockTexx wins Gold for sustainability

GLP-1 weight loss drugs' effect on food and drink choices

Heat and Control announces acquisition of Tek-Dry Systems and Hunt Heat Exchangers

Meat industry handling and freezing solutions on show at IFFA

Making the mark for egg producers

$25K FaBA grant to advance antibiotic detection in food